en
Feedback
NEJM (The New England Journal of Medicine)

NEJM (The New England Journal of Medicine)

Open in Telegram

All the latest articles published on New England Journal of Medicine before going in to print. And all articles from NEJM Evidence Journal. Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot

Show more

📈 Analytical overview of Telegram channel NEJM (The New England Journal of Medicine)

Channel NEJM (The New England Journal of Medicine) (@the_nejm) in the English language segment is an active participant. Currently, the community unites 27 257 subscribers, ranking 757 in the Medicine category and 1 395 in the USA region.

📊 Audience metrics and dynamics

Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 27 257 subscribers.

According to the latest data from 06 September, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 307 over the last 30 days and by 4 over the last 24 hours, overall reach remains high.

  • Verification status: Not verified
  • Engagement rate (ER): The average audience engagement rate is 8.43%. Within the first 24 hours after publication, content typically collects 2.74% reactions from the total number of subscribers.
  • Post reach: On average, each post receives 2 296 views. Within the first day, a publication typically gains 747 views.
  • Reactions and interaction: The audience actively supports content: the average number of reactions per post is 2.
  • Thematic interests: Content is focused on key topics such as medicine, journal, print, cancer, patient.

📝 Description and content policy

The author describes the resource as a platform for expressing subjective opinions:
All the latest articles published on New England Journal of Medicine before going in to print. And all articles from NEJM Evidence Journal. Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicin...

Thanks to the high frequency of updates (latest data received on 07 September, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.

27 257
Subscribers
+424 hours
+457 days
+30730 days
Attracting Subscribers
September '26
September '26
+57
in 0 channels
August '26
+352
in 0 channels
Get PRO
July '26
+410
in 2 channels
Get PRO
June '26
+405
in 0 channels
Get PRO
May '26
+507
in 0 channels
Get PRO
April '26
+397
in 5 channels
Get PRO
March '26
+150
in 0 channels
Get PRO
February '26
+209
in 0 channels
Get PRO
January '26
+274
in 0 channels
Get PRO
December '25
+237
in 0 channels
Get PRO
November '25
+319
in 4 channels
Get PRO
October '25
+398
in 0 channels
Get PRO
September '25
+396
in 0 channels
Get PRO
August '25
+485
in 3 channels
Get PRO
July '25
+473
in 3 channels
Get PRO
June '25
+392
in 0 channels
Get PRO
May '25
+259
in 2 channels
Get PRO
April '25
+72
in 6 channels
Get PRO
March '25
+75
in 3 channels
Get PRO
February '25
+409
in 4 channels
Get PRO
January '25
+40
in 9 channels
Get PRO
December '24
+241
in 6 channels
Get PRO
November '24
+815
in 9 channels
Get PRO
October '24
+961
in 12 channels
Get PRO
September '24
+774
in 8 channels
Get PRO
August '24
+865
in 10 channels
Get PRO
July '24
+2 504
in 18 channels
Get PRO
June '24
+1 490
in 12 channels
Get PRO
May '24
+1 376
in 6 channels
Get PRO
April '24
+1 380
in 1 channels
Get PRO
March '24
+1 472
in 2 channels
Get PRO
February '24
+1 282
in 0 channels
Get PRO
January '24
+1 075
in 1 channels
Get PRO
December '23
+1 039
in 1 channels
Get PRO
November '23
+273
in 1 channels
Get PRO
October '23
+243
in 9 channels
Get PRO
September '23
+165
in 0 channels
Get PRO
August '23
+224
in 0 channels
Get PRO
July '23
+267
in 0 channels
Get PRO
June '23
+268
in 0 channels
Get PRO
May '23
+256
in 0 channels
Get PRO
April '23
+264
in 0 channels
Get PRO
March '23
+277
in 0 channels
Get PRO
February '23
+192
in 0 channels
Get PRO
January '23
+211
in 0 channels
Get PRO
December '22
+170
in 0 channels
Get PRO
November '22
+230
in 0 channels
Get PRO
October '22
+193
in 0 channels
Get PRO
September '22
+256
in 0 channels
Get PRO
August '22
+143
in 0 channels
Get PRO
July '22
+117
in 0 channels
Get PRO
June '22
+174
in 0 channels
Get PRO
May '22
+335
in 0 channels
Get PRO
April '22
+145
in 0 channels
Get PRO
March '22
+140
in 0 channels
Get PRO
February '22
+62
in 0 channels
Get PRO
January '22
+337
in 0 channels
Get PRO
December '21
+94
in 0 channels
Get PRO
November '21
+105
in 0 channels
Get PRO
October '21
+146
in 0 channels
Get PRO
September '21
+157
in 0 channels
Get PRO
August '21
+143
in 0 channels
Get PRO
July '21
+187
in 0 channels
Get PRO
June '21
+204
in 0 channels
Get PRO
May '21
+246
in 0 channels
Get PRO
April '21
+498
in 0 channels
Get PRO
March '21
+732
in 0 channels
Get PRO
February '21
+100
in 0 channels
Get PRO
January '21
+247
in 0 channels
Get PRO
December '20
+2 203
in 0 channels
Date
Subscriber Growth
Mentions
Channels
08 September+6
07 September+6
06 September+4
05 September+13
04 September+6
03 September+12
02 September+5
01 September+5
Channel Posts
Adie Tonic Pupil https://www.nejm.org/doi/full/10.1056/NEJMicm2606883?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

2
The Long Shadow of Bedlam https://www.nejm.org/doi/full/10.1056/NEJMp2600529?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.
937
3
AI-Based Translation of Discharge Instructions — Aligning Policy with Practice https://www.nejm.org/doi/full/10.1056/NEJMp2603777?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.
940
4
The Future of the USPSTF and Evidence-Based Recommendations https://www.nejm.org/doi/full/10.1056/NEJMp2607441?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.
916
5
When Fear Became the Barrier to Care — Lessons of a Clinical Rapid Response during Operation Metro Surge https://www.nejm.org/doi/full/10.1056/NEJMp2607981?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.
852
6
Infigratinib in Achondroplasia — A Potentially Giant Step Forward https://www.nejm.org/doi/full/10.1056/NEJMe2609749?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 9, Page 919-920, September 3, 2026.
1 538
7
Fluid Resuscitation in Patients with Sepsis — For Whom the Balance Tolls https://www.nejm.org/doi/full/10.1056/NEJMe2609856?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 9, Page 921-922, September 3, 2026.
1 426
8
Case 20-2026: A 38-Year-Old Man with Abdominal Pain https://www.nejm.org/doi/full/10.1056/NEJMx260023?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 9, Page 936-936, September 3, 2026.
1 276
9
Hypomethylating Agents plus Venetoclax as Compared with Intensive Chemotherapy in Patients with AML https://www.nejm.org/doi/full/10.1056/NEJMe2607967?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 9, Page 917-919, September 3, 2026.
1 197
10
A Zoonotic Orthonairovirus from Febrile Patients in China https://www.nejm.org/doi/full/10.1056/NEJMc2602496?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 9, Page 929-931, September 3, 2026.
1 048
11
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders https://www.nejm.org/doi/full/10.1056/NEJMc2603114?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 9, Page 926-929, September 3, 2026.
988
12
Childhood Vaccine Hesitancy https://www.nejm.org/doi/full/10.1056/NEJMc2608837?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 9, Page 933-934, September 3, 2026.
991
13
More on Causes of Death among Children and Adolescents in the United States https://www.nejm.org/doi/full/10.1056/NEJMc2608518?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 9, Page 934-936, September 3, 2026.
994
14
Telitacicept for IgA Nephropathy https://www.nejm.org/doi/full/10.1056/NEJMc2608517?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 9, Page 931-933, September 3, 2026.
911
15
Physical Examination for Asymptomatic Adults https://www.nejm.org/doi/full/10.1056/NEJMclde2515158?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 9, Page 923-925, September 3, 2026.
931
16
Acro-Osteolysis https://www.nejm.org/doi/full/10.1056/NEJMicm2605116?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 9, September 3, 2026.
933
17
NEJM Interview: Elizabeth Tobin-Tyler on the legal argument that permitting telehealth access to mifepristone can abet reproductive coercion. http://www.nejm.org/doi/full/10.1056/NEJMp2608826 Elizabeth Tobin-Tyler is a professor of health services, policy and practice at the Brown University School of Public Health and of family medicine and medical science at Warren Alpert Medical School of Brown University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E. Tobin-Tyler and G. Chalker. Telehealth Access to Mifepristone — Evaluating Reproductive-Coercion Arguments. N Engl J Med 2026;395:833-835.
1 370
18
NEJM This Week — September 3, 2026 http://www.nejm.org/toc/nejm/395/9 This week, we feature new research on acute myeloid leukemia, achondroplasia, pediatric septic shock, and RAS-mutant lung cancer. We also review the evaluation and management of pulmonary nodules and follow a diagnostic case of recurrent fractures. Perspectives explore reproductive health care, the human–animal bond in health care access, and on creating space for patients’ voices in clinical decision making.
1 252
19
Catheter-Directed Thrombolysis in Intermediate-High–Risk Pulmonary Embolism https://www.nejm.org/doi/full/10.1056/NEJMoa2608012?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.
1 586
20
Immediate Ambulatory Electrocardiographic Monitoring in Syncope https://www.nejm.org/doi/full/10.1056/NEJMoa2605812?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.
1 858